Belgian Mitraclip Registry

Universiteit Antwerpen

Status: Completed

Conditions: Mitral Valve Insufficiency

Treatments: Device: mitraclip

Study type: Observational

Funder types: Other

Identifiers

NCT02506387

BEL 0

Details and patient eligibility

About

The primary objective of the registry is to investigate and follow all patients treated with the MitraClip System in Belgium. This information is intended to contribute to decision making with regards to MitraClip therapy selection in patients with mitral regurgitation: (a) by establishing the clinical value of the MitraClip therapy in the continuum of care; and (b) by providing practical information that will allow physicians to make therapeutic decisions, assist hospitals to make purchasing decisions, and assist insurers/government in making coverage decisions.

In addition national data will be shared with European registries in order to increase the knowledge about the efficacy of this new technique.

Enrollment: 520 patients

Sex: All

Ages: 25 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• severe mitral regurgitation
• symptomatic (NYHA class>1) despite optimal medical therapy
• suitable anatomy for mitraclip implantation
• too high risk for cardiac surgery

Exclusion criteria

• <1 year life expectancy

Trial design

520 participants in 1 patient group

Mitraclip patients

Description:

Patients with severe mitral regurgitation in whom decision for mitraclip implantation was made by the heart team.

Treatment:

Device: mitraclip